Jan F. Esser Jan F. Esser Johannes "Jan" Fredericus Samuel Esser (13 October 1877 in Leiden – 9 August 1946 in Chicago) was a Dutch plastic surgeon who pioneered innovative methods of reconstructive surgery on soldiers wounded in the First World War. He is thought to have coined the term "stent" in 1917 to describe his use of a dental impression compound invented in 1856 by the English dentist Charles Stent (1807–1885) to create a form for facial reconstruction. The term "stent" was later extended to mean a device to expand constricted tubes of body tissue. He was a one time Dutch Chess
Cypher stent that it will stop selling Cypher stents by the end of 2011. Cypher stent Cypher is a brand of drug-eluting coronary stent from Cordis Corporation, a Cardinal Health company. During a balloon angioplasty, the stent is inserted into the artery to provide a "scaffold" to open the artery. An anti-rejection-type medication, sirolimus, helps to limit the overgrowth of normal cells while the artery heals which reduces the chance of re-blockage in the treated area known as restenosis, and reduces the chances that another procedure is required. The Cypher stent was approved for use by the FDA in 2003. Following claims